NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
9 trialsNCT01838317 2021-03-01
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT02347813 2020-06-23
Preventing Squamous Cell Skin Cancer
University of Rochester
Phase 2 Completed
NCT02730195 2019-01-09
Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Emory University
Phase 2 Terminated
NCT01342770 2017-12-05
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT01655719 2017-10-26
Pioglitazone in Thyroid Cancers
University of Michigan
Phase 2 Completed
NCT00427999 2016-11-21
INV342
Novartis
Phase 2 Completed
NCT00951379 2016-04-06
Pioglitazone for Oral Premalignant Lesions
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00923949 2015-09-30
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated